FR2833012B1 - Peptides agonistes de l'hormone de croissance et leurs applications - Google Patents

Peptides agonistes de l'hormone de croissance et leurs applications

Info

Publication number
FR2833012B1
FR2833012B1 FR0115641A FR0115641A FR2833012B1 FR 2833012 B1 FR2833012 B1 FR 2833012B1 FR 0115641 A FR0115641 A FR 0115641A FR 0115641 A FR0115641 A FR 0115641A FR 2833012 B1 FR2833012 B1 FR 2833012B1
Authority
FR
France
Prior art keywords
applications
growth hormone
agonistic peptides
agonistic
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0115641A
Other languages
English (en)
Other versions
FR2833012A1 (fr
Inventor
Claude Carelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0115641A priority Critical patent/FR2833012B1/fr
Priority to AU2002364314A priority patent/AU2002364314A1/en
Priority to PCT/FR2002/004149 priority patent/WO2003048206A2/fr
Publication of FR2833012A1 publication Critical patent/FR2833012A1/fr
Application granted granted Critical
Publication of FR2833012B1 publication Critical patent/FR2833012B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
FR0115641A 2001-12-04 2001-12-04 Peptides agonistes de l'hormone de croissance et leurs applications Expired - Lifetime FR2833012B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0115641A FR2833012B1 (fr) 2001-12-04 2001-12-04 Peptides agonistes de l'hormone de croissance et leurs applications
AU2002364314A AU2002364314A1 (en) 2001-12-04 2002-12-03 Growth hormone agonist peptides and their uses
PCT/FR2002/004149 WO2003048206A2 (fr) 2001-12-04 2002-12-03 Peptides agonistes de l'hormone de croissance et leurs applications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0115641A FR2833012B1 (fr) 2001-12-04 2001-12-04 Peptides agonistes de l'hormone de croissance et leurs applications

Publications (2)

Publication Number Publication Date
FR2833012A1 FR2833012A1 (fr) 2003-06-06
FR2833012B1 true FR2833012B1 (fr) 2004-01-30

Family

ID=8870076

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0115641A Expired - Lifetime FR2833012B1 (fr) 2001-12-04 2001-12-04 Peptides agonistes de l'hormone de croissance et leurs applications

Country Status (3)

Country Link
AU (1) AU2002364314A1 (fr)
FR (1) FR2833012B1 (fr)
WO (1) WO2003048206A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2414897C2 (ru) 2005-11-30 2011-03-27 Нестек С.А. Способы лечения потери мышечной массы
US8975225B2 (en) * 2009-03-19 2015-03-10 Universite Pierre Et Marie Curie (Paris 6) Method for inhibiting growth of chondrocytes in a subject by inhibiting IGF-1
RU2018145945A (ru) 2016-06-10 2020-07-10 Регулаксис Пептид для лечения остеоартрита, фармацевтическая композиция, лекарственное средство, единичная дозированная форма

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4316891A (en) * 1980-06-14 1982-02-23 The Salk Institute For Biological Studies Extended N-terminal somatostatin
GB8707398D0 (en) * 1987-03-27 1987-04-29 Coopers Animal Health Biologically active molecules
GB8718937D0 (en) * 1987-08-11 1987-09-16 Coopers Animal Health Biologically active molecules
FR2694885B1 (fr) * 1992-08-20 1994-10-07 Rhone Merieux Procédé pour améliorer la croissance et la qualité des carcasses des animaux domestiques producteurs de viande, ensemble de vaccination et vaccins.
FR2744123B1 (fr) * 1996-01-26 1998-04-17 Carelli Claude Marcel Henri Molecules biologiquement actives plus particulierement peptidiques ayant un effet potentialisateur de l'activite biologique de l'hormone de croissance

Also Published As

Publication number Publication date
AU2002364314A1 (en) 2003-06-17
FR2833012A1 (fr) 2003-06-06
WO2003048206A3 (fr) 2003-12-11
WO2003048206A2 (fr) 2003-06-12
AU2002364314A8 (en) 2003-06-17

Similar Documents

Publication Publication Date Title
FR12C0012I2 (fr) Combinaisons d'herbicides et de phytoprotecteurs
FR2831769B1 (fr) Facteur d'appetence et exhausteur de gout
DE60136181D1 (de) 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden
DE60233192D1 (de) Hydrophobe und lipophobe zusammensetzung
AU6723401A (en) Antimicrobial peptides and methods of use thereof
DK1462455T3 (da) Ser-Ser-Ser-Arg-peptid samt medicinske anvendelser deraf
FR2831732B1 (fr) Fourniture d'images numeriques geolocalisees personnalisees
NO20042693L (no) Kateterpreparat og anvendelser derav
IL152202A0 (en) Human kcnq5 polypeptide and pharmaceutical compositions containing the same
EP1254242A4 (fr) 17 proteines secretees humaines
FR2833012B1 (fr) Peptides agonistes de l'hormone de croissance et leurs applications
EP1368468A4 (fr) 83 proteines humaines secretes
EE200300483A (et) Uudsed ekspressioonivektorid ja nende rakendused
HUP0401589A3 (en) New peptides - analogs of human growth hormone-releasing hormone
EP1474166A4 (fr) Proteines de formation de liaison disulfure et utilisation de ces dernieres
IL150231A0 (en) Human cystine knot polypeptide
EP1370651A4 (fr) 70 proteines humaines secretees
EP1357129A4 (fr) Nouveau peptide physiologiquement actif et son utilisation
IL153740A0 (en) Grf2-binding proteins and applications thereof
FR2832922B1 (fr) Prothese d'epaule
AU2002365153A1 (en) 41 human secreted proteins
EP1317472A4 (fr) 17 proteines humaines secretees
EP1322657A4 (fr) Proteines secretees humaines 22
ITMI20011833A0 (it) Agenti che regolano la permeabilita' vascolare
AU2002327176A1 (en) 20 human secreted proteins

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20